CORT

#1372
Corcept Therapeutics Inc.
43.6800 USD
+0.88%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
43.6800
43.6800
Jahresspanne
28.6601
89.0000
Tagesänderung
+0.88%
Monatliche Änderung
+34.98%
6 month change
-40.47%
Jahresänderung
-40.47%
Vorheriger Schlusskurs
43.3000
Eröffnung
43.6800
Bid
Ask
Tief
43.6800
High
43.6800
Volumen
71
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
Gewinn- und Verlustrechnung Bilanz Cashflow
Wert 202020212022202320242025 TTM

Corcept Therapeutics Incorporated

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Nachrichten